Application of a hypoxia metric to investigate tumor mutational burden and cancer cell immunogenicity in vitro.

被引：0
|
作者：
Abou Khouzam, Raefa [1 ]
Zeinelabdin, Nagwa Ahmed [1 ]
Sharda, Mohak [2 ]
Nawafleh, Husam [1 ]
Mahmood, Ayda Shah [1 ]
Khan, Munazza Samar [1 ]
Venkatesh, Goutham Hassan [1 ]
Chouaib, Salem [1 ]
Rao, Shyama Prasad [3 ]
机构：
[1] Gulf Med Univ, Ajman, U Arab Emirates
[2] Natl Ctr Biol Sci, Tata Inst Fundamental Res, Bangalore, Karnataka, India
[3] Yenepoya Univ, Yenepoya Res Ctr, Mangalore, India
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5679
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Tumor mutational burden in Japanese patients with triple negative breast cancer
    Kurata, Kanako
    Kubo, Makoto
    Yuan, Yuan
    Harada, Yurina
    Morisaki, Takafumi
    Shimazaki, Akiko
    Hayashi, Saori
    Kawaji, Hitomi
    Kaneshiro, Kazuhisa
    Yamada, Mai
    Kai, Masaya
    Nakamura, Masafumi
    CANCER RESEARCH, 2020, 80 (04)
  • [42] Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
    Hellmann, M. D.
    Ciuleanu, T. -E.
    Pluzanski, A.
    Lee, J. S.
    Otterson, G. A.
    Audigier-Valette, C.
    Minenza, E.
    Linardou, H.
    Burgers, S.
    Salman, P.
    Borghaei, H.
    Ramalingam, S. S.
    Brahmer, J.
    Reck, M.
    O'Byrne, K. J.
    Geese, W. J.
    Green, G.
    Chang, H.
    Szustakowski, J.
    Bhagavatheeswaran, P.
    Healey, D.
    Fu, Y.
    Nathan, F.
    Paz-Ares, L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (22): : 2093 - 2104
  • [43] Effects of imatinib on breast cancer cell biology in vitro.
    Mundhenke, C
    Weigel, M
    Schmidt, SR
    Meinhold-Heerlein, I
    Schem, C
    Bauerschlag, DO
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 243S - 243S
  • [44] Impact of high tumor mutational burden in solid tumors and challenges for biomarker application
    McNamara, Mairead G.
    Jacobs, Timothy
    Lamarca, Angela
    Hubner, Richard A.
    Valle, Juan W.
    Amir, Eitan
    CANCER TREATMENT REVIEWS, 2020, 89
  • [45] Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer
    Chae, Young Kwang
    Davis, Andrew A.
    Agte, Sarita
    Pan, Alan
    Simon, Nicholas I.
    Iams, Wade T.
    Cruz, Marcelo R.
    Tamragouri, Keerthi
    Rhee, Kyunghoon
    Mohindra, Nisha
    Villaflor, Victoria
    Park, Wungki
    Lopes, Gilberto
    Giles, Francis J.
    ONCOLOGIST, 2019, 24 (06): : 820 - 828
  • [46] Letter to the Editor: Could Immunogenicity of Kaposi Sarcoma Be More Linked to Viral Antigens Than to the Tumor Mutational Burden?
    Delyon, Julie
    Arangalage, Dimitri
    Baroudjian, Barouyr
    Lebbe, Celeste
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2018, 16 (12): : 1418 - 1419
  • [47] Association of tumor mutational burden with smoking and mutation status in non-small cell lung cancer (NSCLC).
    Davis, Andrew A.
    Chae, Young Kwang
    Agte, Sarita
    Pan, Alan
    Mohindra, Nisha Anjali
    Villaflor, Victoria Meucci
    Giles, Francis J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [48] INVESTIGATING THE ROLE OF MUTATIONAL BURDEN IN TUMOR IMMUNOGENICITY USING A PRE-CLINICALMLH1-DEFICIENT GLIOBLASTOMA MODEL
    Haynes, Tuesday
    Breen, Kevin
    Zhang, Meili
    Song, Hua
    Davis, Dionne
    Briceno, Nicole
    Wong, Zalman
    Li, Aiguo
    Watanabe, Masashi
    Gilbert, Mark
    NEURO-ONCOLOGY, 2024, 26
  • [49] Comparative analysis of three NGS platforms assessing tumor mutational burden and mutational landscape in resectable non-small cell lung cancer
    Lee, J. B.
    Choi, S. J.
    Kim, J. H.
    Hong, M. H.
    Cho, B. C.
    Lim, S. M.
    ANNALS OF ONCOLOGY, 2023, 34 : S1649 - S1649
  • [50] KMT2C mutation associated with tumor mutational burden in small cell lung cancer.
    Gu, Weiguang
    Wang, Hongbiao
    Li, Kunsong
    Wei, Ge
    Zhang, Junkai
    Zhang, Shiyue
    Zhang, Lin
    Shi, Xiaoliang
    Liu, Angen
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345